Ono Pharmaceutical Co., Ltd. announced that it has entered into a research collaboration agreement with InveniAI® LLC, to identify novel therapeutic targets by leveraging cutting-edge InveniAI’s artificial intelligence and machine learning.
Ono Pharmaceutical Co., Ltd. announced that it has entered into a research collaboration agreement with InveniAI® LLC, to identify novel therapeutic targets by leveraging cutting-edge InveniAI’s artificial intelligence and machine learning.